Monte Rosa Therapeutics, Inc. (GLUE) Operating margin 2024–2025
Monte Rosa Therapeutics, Inc. (GLUE) operating margin by fiscal year — reported operating income divided by reported revenue.
-43.8%FY2025 · since FY2024: -107.3% → -43.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -43.8% | +63.4 pp |
| FY2024 | -107.3% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More GLUE financial trends
GLUE RevenueGLUE Net incomeGLUE Net marginGLUE Gross profitGLUE Gross marginGLUE Operating incomeGLUE Operating cash flowGLUE Free cash flowGLUE Capital expendituresGLUE Return on equityGLUE Stock buybacksGLUE Dividends paidGLUE Total assetsGLUE Total liabilitiesGLUE Shareholders’ equityGLUE overview →